3 hours Novo Nordisk A/S (NYSE:NVO) Price Target Cut to $156.00 by Analysts at BMO Capital MarketsMarketBeat
BMO Capital Markets decreased their price objective on shares of Novo Nordisk A/S from $160.00 to $156.00 and set an “outperform” rating for the company in a research note on Thursday.
X